Correlation Between GILEAD and Catalyst Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GILEAD and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GILEAD and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GILEAD SCIENCES INC and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on GILEAD and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GILEAD with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GILEAD and Catalyst Pharmaceuticals.

Diversification Opportunities for GILEAD and Catalyst Pharmaceuticals

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between GILEAD and Catalyst is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding GILEAD SCIENCES INC and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and GILEAD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GILEAD SCIENCES INC are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of GILEAD i.e., GILEAD and Catalyst Pharmaceuticals go up and down completely randomly.

Pair Corralation between GILEAD and Catalyst Pharmaceuticals

Assuming the 90 days trading horizon GILEAD is expected to generate 961.0 times less return on investment than Catalyst Pharmaceuticals. But when comparing it to its historical volatility, GILEAD SCIENCES INC is 9.21 times less risky than Catalyst Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1,974  in Catalyst Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  233.00  from holding Catalyst Pharmaceuticals or generate 11.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.31%
ValuesDaily Returns

GILEAD SCIENCES INC  vs.  Catalyst Pharmaceuticals

 Performance 
       Timeline  
GILEAD SCIENCES INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GILEAD SCIENCES INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, GILEAD is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

GILEAD and Catalyst Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GILEAD and Catalyst Pharmaceuticals

The main advantage of trading using opposite GILEAD and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GILEAD position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.
The idea behind GILEAD SCIENCES INC and Catalyst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.